InceptionR’s Mirum Pharmaceuticals MIRM Stock Holding History

InceptionR’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$951K	Buy	8,122 +3,564	+78%	+$358K	0.23%	137
2026 Q1	$421K	Buy	+4,558	New	+$429K	0.1%	369

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

InceptionR's MIRM Position: Q2 2026 in Review

InceptionR increased its Mirum Pharmaceuticals (MIRM) stake by 78% in Q2 2026, buying an estimated $358K and bringing the position to 8,122 shares worth $951K. The position accounts for 0.23% of the portfolio, ranked #137.

InceptionR first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

InceptionR held 8,122 shares of Mirum Pharmaceuticals worth $951K as of Q2 2026.
InceptionR bought 3,564 Mirum Pharmaceuticals shares in Q2 2026, an estimated $358K.
Mirum Pharmaceuticals made up 0.23% of InceptionR's portfolio in Q2 2026, its #137 holding.
InceptionR first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.